Your search history is turned on.
Date: March 29, 2017 Jurisdictions: Alberta, British Columbia, Ontario
ASC Form 13-501F1 -- Fillable Template (s) Name: Date: Title: ReportingIssuerName: Enddateofpreviousfinancialyear: TypeofReportingIssuer: Class1ReportingIssuer Class3BReportingIssuer HighestTradingMarketplace: Marketvalueoflistedorquotedequitysecurities: EquitySymbol to $ (i) (ii) Marketvalueofclassorseri...
Date: January 18, 2017 Jurisdictions: Alberta, British Columbia, Ontario
20161230 Liberty Biopharma Amalgamation Certificate Number: BC1102311 CERTIFICATE OF AMALGAMATION BUSINESS CORPORATIONS ACT I Hereby Certify that AVAPECIA LIFE SCIENCES CORP., incorporation number BC1003976, and LIBERTY BIOPHARMA INC., incorporation number C1102183 were amalgamated as one company under the name LIBERTY BIOPHARMA INC. on Dece...
Microsoft Word - Notice of Change in Corporate Structure.docx NOTICE OF CHANGE IN CORPORATE STRUCTURE National Instrument 51-102 Section 4.9 This notice is provided pursuant to the requirements of Section 4.9 of National Instrument 51-102 Continuous Disclosure Obligations (NI 51-102). Item 1 Names of the parties to the transaction Avagenesis Corp...
Date: January 11, 2017 Jurisdictions: British Columbia, Ontario
Form 51-102F3 Material Change Report (Avapecia) FORM 51-102F3 Material Change Report 1. Name and Address of Company: Avapecia Life Sciences Corp. 2270-8788 McKim Way Richmond, British Columbia V6X 4E2 2. Date of Material Change: January 3, 2017 3. News Release: The news release with respect to the material c...
Date: January 3, 2017 Jurisdictions: British Columbia, Ontario
January 3, 2017 Avagenesis and Avapecia Complete Merger and Continue as Liberty Biopharma Inc. January 3, 2017 Richmond, British Columbia: Avagenesis Corp. (TSXV: VVA; Avagenesis) and Avapecia Life Sciences Corp. (CSE: VVS; Avapecia) (collectively referred to as the Companies) are pleased to announce the completion of the transactions contemplated in th...
Date: December 16, 2016 Jurisdictions: British Columbia, Ontario
20161216 VVA VVS Announce SH Approval of Amalgamation (FINAL) Avagenesis and Avapecia Announce Shareholder Approval of Amalgamation December 16, 2016, Vancouver, British Columbia Avagenesis Corp. (TSXV: VVA) (Avagenesis) and Avapecia Life Sciences Corp. (CSE: VVS) (Avapecia) are pleased to announce that the amalgamatio...
Date: December 8, 2016 Jurisdictions: British Columbia, Ontario
Microsoft Word - 20161207 VVA and VVS Bckgrd on Proposed Merger vfinal.docx Avagenesis and Avapecia Jointly Provide Additional Disclosure With Respect to the Amalgamation December 8, 2016 Calgary, Alberta and Richmond, British Columbia: Avagenesis Corp. (TSXV: VVA; Avagenesis) and Avapecia Life Sciences Corp. (CSE: VVS; Avapecia) (collectively referred to...
Date: November 22, 2016 Jurisdictions: British Columbia, Ontario
- SEE VOTING GUIDELINES ON REVERSE - RESOLUTIONS MANAGEMENT VOTING RECOMMENDATIONS ARE INDICATED BY HIGHLIGHTED TEXT ABOVE THE BOXES 1. Number of Directors FOR AGAINST To set the number of Directors at minimum 3 and maximum 8. 2. Election of Directors FOR WITHHOLD a) Dennis Nerland ...
2 AVAPECIA LIFE SCIENCES CORP. NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN that an annual general and special meeting of the shareholders of Avapecia Life Sciences Corp. (Avapecia or the Corporation) will be held in the boardroom of Buttonwood Law Corporation, 11th floor, 1111 Melville Street, Vancouver, Britis...
2016 VVS MIC V.8 - (FINAL) Avapecia Life Sciences Corp. 2270-8788 McKim Way Richmond, British Columbia V6X 4E2 Tel: 1-604-377-7575 1 AVAPECIA LIFE SCIENCES CORP. ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS To be held December 13, 2016 NOTICE OF MEETING AND MAN...